MPO generates nitrotyrosine in the subendothelial space

December 12, 2001

Inflamed vascular tissue provides an interesting example of a pathological form of protein modification occurring outside the cell. Vascular ECM components, particularly the prominent interstitial protein fibronectin, readily undergo tyrosine nitration during the inflammatory process. Still, as Baldus et al. note, the mechanism of this post-translational modification and the basis of its localization have been uncertain. Striking images in their present report show that the oxidative enzyme myeloperoxidase (MPO) colocalizes with fibronectin in inflamed vessels. This finding provides a ready explanation for the specific accumulation of nitrotyrosine residues in the subendothelial space, but it also raises the question of how an enzyme produced in the lumen of the vessel by activated neutrophils can then traverse the endothelium. Baldus et al. show that following degranulation of neutrophils, MPO associates with endothelial heparan sulfate proteoglycans and is transcytosed to the basolateral side of cultured endothelial cells (and to the corresponding ablumenal face of the endothelium in vivo). There, MPO, activated by peroxide, oxidizes free nitrite, which can then modify neighboring ECM proteins. Whereas nitrotyrosine has previously been thought to form spontaneously in the presence of the peroxynitrite radical (itself a secondary product of the simple signaling molecule NO), the present work places a new emphasis on MPO as a mediator of tyrosine nitration. Indeed, the authors show that, following treatment to provoke systemic inflammation, the liver of animals lacking MPO is significantly poorer in protein nitrotyrosine adducts than wild-type liver. The physiological significance of MPO transcytosis remains unresolved, but the MPO knockout mouse may provide a useful system for testing the role of localized protein nitration in the onset, progression, or termination of vascular inflammation.

JCI Journals

Related Neutrophils Articles from Brightsurf:

The unexpected repair function of neutrophils
Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have discovered that neutrophils, the most abundant cells of the innate immune system, have many more functions in the body than previously thought.

Cells sacrifice themselves to boost immune response to viruses
Whether flu or coronavirus, it can take several days for the body to ramp up an effective response to a viral infection.

LJI team gets first-ever look at a rare but vital stem cell in humans
Scientists at La Jolla Institute for Immunology (LJI) have tracked down the rare stem cells that generate neutrophils in human bone marrow.

COVID-19 - The virus and the vasculature
In severe cases of COVID-19, the infection can lead to obstruction of the blood vessels in the lung, heart and kidneys.

How rod-shaped particles might distract an out-of-control COVID immune response
A long-ignored white blood cell may be central to the immune system overreaction that is the most common cause of death for COVID-19 patients--and University of Michigan researchers found that rod-shaped particles can take them out of circulation.

A better model for neutrophil-related diseases
Neutrophils are critical immune cells for antimicrobial defense, but they can exacerbate a number of diseases, perhaps including COVID-19.

Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease
The authors determined that tumor-derived ANGPTL2 stimulates lung epithelial cells, which is essential for primary tumor-induced neutrophil recruitment in lung and subsequent pre-metastatic niche formation.

Neutrophils are equipped with a 'disarmament' program that prevents the immune system going 'out of control'
The new finding, published in Nature Immunology, could have major implications for the understanding and treatment of disorders such as myocardial infarction, stroke, and acute inflammatory processes.

Scientists link common immune cell to failure of checkpoint inhibitors in lung cancer
For many lung cancer patients, the best treatment options involve checkpoint inhibitors, but the drugs only help a small subset of patients.

New technology promises improved treatment of inflammatory diseases
A study led by researchers at Washington State University has uncovered a potential new treatment approach for diseases associated with inflammation, including sepsis and stroke.

Read More: Neutrophils News and Neutrophils Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to